CytomX Therapeutics (CTMX) Interest Coverage Ratio (2014 - 2025)
CytomX Therapeutics (CTMX) posted Interest Coverage Ratio of 1.14 for Q4 2025, up 63.99% on a QoQ basis from 3.15 in Q3 2025, and down 114.78% year-over-year from 7.69 in Q4 2024.
CytomX Therapeutics (CTMX) Interest Coverage Ratio (2014 - 2025) Analysis & Trends
CytomX Therapeutics' Interest Coverage Ratio history runs 12 years deep, the most recent figure standing at 1.14 for Q4 2025.
- Quarterly Interest Coverage Ratio fell 114.78% year-over-year to 1.14 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was 49.39 (down 800.56% YoY) and the FY2025 annual result came in at 0.91, down 689.76% from the prior year.
- Interest Coverage Ratio was 1.14 for Q4 2025 at CytomX Therapeutics, up from 3.15 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 7.69 in Q4 2024 and bottomed at 37.37 in Q3 2022.
- A 5-year average of 9.22 and a median of 2.63 in 2025 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio sank 439.79% — and 2024, when it soared 222646.37%.
- CytomX Therapeutics' Interest Coverage Ratio stood at 26.66 in 2021, then jumped by 84.5% to 4.13 in 2022, then surged by 99.92% to 0.0 in 2023, then surged by 222646.37% to 7.69 in 2024, then sank by 114.78% to 1.14 in 2025.
- Business Quant data shows CTMX's Interest Coverage Ratio at 1.14 in Q4 2025, 3.15 in Q3 2025, and 0.25 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | CytomX Therapeutics | 590.32 Mn | 243.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.14 |
| Sep 30, 2025 | -3.15 |
| Jun 30, 2025 | -0.25 |
| Mar 31, 2025 | 4.44 |
| Dec 31, 2024 | 7.69 |
| Sep 30, 2024 | 1.00 |
| Jun 30, 2024 | -2.11 |
| Mar 31, 2024 | 2.99 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 1.12 |
| Dec 31, 2022 | -4.13 |
| Sep 30, 2022 | -37.37 |
| Jun 30, 2022 | -25.86 |
| Mar 31, 2022 | -34.89 |
| Dec 31, 2021 | -26.66 |
| Sep 30, 2021 | -24.38 |
| Jun 30, 2021 | -4.79 |
| Mar 31, 2021 | -18.38 |
| Dec 31, 2020 | -18.91 |
| Sep 30, 2020 | -20.35 |